{
    "clinical_study": {
        "@rank": "112572", 
        "acronym": "mdp", 
        "arm_group": {
            "arm_group_label": "STEM CELL", 
            "arm_group_type": "Other", 
            "description": "Intra thecal transplantation of autologous Stem Cell MNCs"
        }, 
        "brief_summary": {
            "textblock": "This Study is single arm, single centre trial to check the safety and efficacy of Bone\n      Marrow derived autologous cell(100 million per dose) for the patient with Duchenne Muscular\n      Dystrophy."
        }, 
        "brief_title": "Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Muscular Dystrophy", 
            "Duchenne Muscular Dystrophy,"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Muscular Dystrophy, Duchenne", 
                "Muscular Dystrophies"
            ]
        }, 
        "detailed_description": {
            "textblock": "Muscular dystrophy is a group of inherited disorders that involve muscle weakness and loss\n      of muscle tissue, which get worse over time. Duchenne muscular dystrophy is caused by a\n      defective gene for dystrophin (a protein in the muscles). However, it often occurs in people\n      without a known family history of the condition. slowly progress diseases.it causes Muscle\n      weaknesses, Difficulty with motor skills ,Progressive difficulty walking.Breathing\n      difficulties and heart disease,Frequent falls,weak limbs,lose motor Function.Begins in the\n      legs and pelvis, but also occurs less severely in the arms, neck, and other areas of the\n      body.Trouble getting up from a lying position or climbing stairs."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient with Diagnose of Duchenne Muscular Dystrophy.\n\n          -  Aged in between 6 to 25 Years.\n\n          -  Willingness to undergo Bone Marrow derived Autologous cell Therapy.\n\n          -  Ability to comprehend the explained protocol and thereafter give an informed\n             consent as well as sign the required Informed Consent form(ICF) for the study.\n\n          -  Ability and willingness to regular visit to hospital for protocol procedures and\n             follow up\n\n        Exclusion Criteria:\n\n          -  Patient who is not Diagnose of Duchenne Muscular Dystrophy.\n\n          -  Patient with History of Immunodeficiency  HIV+,Hepatitis B ,HBV and   TPPA+,Tumor\n             Markers+\n\n          -  History of Life threatening  allergic or immune -Mediated Reaction.\n\n          -  the site of bone marrow aspiration potentially limiting Procedure.\n\n          -  Alcohol and drug abuse / dependence.\n\n          -  Patients with History of Hypertension and Hypersensitive."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "25 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01834066", 
            "org_study_id": "00101"
        }, 
        "intervention": {
            "arm_group_label": "STEM CELL", 
            "description": "Intralesional transfer of Autologous Stem cell (MNCs) per dose. 6 doses in 3 months", 
            "intervention_name": "Stem Cell", 
            "intervention_type": "Biological", 
            "other_name": "Intravenous transfer of Autologous Stem Cell ( MNCs )"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "muscular Dystrophy stem cell", 
        "lastchanged_date": "April 15, 2013", 
        "location": {
            "contact": {
                "email": "sac2751982@gmail.com", 
                "last_name": "Sachin P Jamadar, D ORTHO", 
                "phone": "+918888788880"
            }, 
            "contact_backup": {
                "email": "drsmitabhoyar@rediffmail.com", 
                "last_name": "Smita S Bhoyar, BAMS.PGCR", 
                "phone": "9372620569"
            }, 
            "facility": {
                "address": {
                    "city": "Pune", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "411009"
                }, 
                "name": "Chaitnany Hospital"
            }, 
            "investigator": {
                "last_name": "ANANT E BAGUL, MS ORTHO", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "Safety and Efficacy of Bone Marrow Autologous Cells in Muscular Dystrophy.", 
        "overall_contact": {
            "email": "sac2751982@gmail.com", 
            "last_name": "Sachin P Jamadar, D.Ortho", 
            "phone": "+918888788880"
        }, 
        "overall_contact_backup": {
            "email": "drsmitabhoyar@rediff.com", 
            "last_name": "Smita S Bhoyar, B.A.M.S.PGCR", 
            "phone": "9372620569"
        }, 
        "overall_official": {
            "affiliation": "CHAITANYA HOSPITAL", 
            "last_name": "ANANT E BAGUL, MS ORTHO", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Significant Improvement in Muscle strength by using Kinetics Muscle testing or by using MMT( manual muscle test }score", 
            "safety_issue": "Yes", 
            "time_frame": "6 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01834066"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chaitanya Hospital, Pune", 
            "investigator_full_name": "Dr. Sachin Jamadar", 
            "investigator_title": "C0-  Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "-Improvement of daily living scale and baseline in EMG(electromyography)", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "source": "Chaitanya Hospital, Pune", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chaitanya Hospital, Pune", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}